Presentation is loading. Please wait.

Presentation is loading. Please wait.

Postoperative Prognosis in Patients with Non-small Cell Lung Cancer According to the Method of Initial Detection  Takeshi Hanagiri, MD, PhD, Kenji Sugio,

Published byMoris Parks Modified over 6 years ago

Similar presentations

Presentation on theme: "Postoperative Prognosis in Patients with Non-small Cell Lung Cancer According to the Method of Initial Detection  Takeshi Hanagiri, MD, PhD, Kenji Sugio,"— Presentation transcript:

1 Postoperative Prognosis in Patients with Non-small Cell Lung Cancer According to the Method of Initial Detection  Takeshi Hanagiri, MD, PhD, Kenji Sugio, MD, PhD, Makiko Mizukami, MD, PhD, Yoshinobu Ichiki, MD, PhD, Masakazu Sugaya, MD, PhD, Kenji Ono, MD, Manabu Yasuda, MD, PhD, Tadahiro Nozoe, Mitsuhiro Takenoyama, MD, PhD, Kosei Yasumoto, MD, PhD  Journal of Thoracic Oncology  Volume 2, Issue 10, Pages (October 2007) DOI: /JTO.0b013e c Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Overall survival curves of patients with pathologic stage I disease. Among the stage I patients, the 5-year survival rates were 83.3%, 69.9%, and 66.3% in groups I, II, and III, respectively. Group I tended to have more favorable prognoses than groups II (p = 0.11) and III (p = 0.08). Journal of Thoracic Oncology 2007 2, DOI: ( /JTO.0b013e c) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Overall survival curves of patients with lung cancer. The 5-year survival rates were 71.9%, 60.2%, and 48.0% in groups I, II, and III, respectively. Group I had significantly more favorable prognoses than group III (p < 0.001). Journal of Thoracic Oncology 2007 2, DOI: ( /JTO.0b013e c) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Cancer-specific survival of patients with stage I disease. With the exception of death due to unrelated disease, the 5-year survival rates 89.4%, 88.7%, and 80.7% in groups I, II, and III, respectively. Groups I and II tended to have favorable prognoses than group III (p < 0.07). Journal of Thoracic Oncology 2007 2, DOI: ( /JTO.0b013e c) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Cancer-specific survival of patients with lung cancer. With the exception of death due to unrelated disease, the 5-year survival rates were 76.3%, 75.6%, and 58.2% in groups I, II, and III, respectively. Groups I and II had significantly more favorable prognoses than group III (p < 0.001). Journal of Thoracic Oncology 2007 2, DOI: ( /JTO.0b013e c) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Postoperative Prognosis in Patients with Non-small Cell Lung Cancer According to the Method of Initial Detection  Takeshi Hanagiri, MD, PhD, Kenji Sugio,"

Similar presentations

Su K. Metcalfe, MD, MPH, Michael T

Su K. Metcalfe, MD, MPH, Michael T
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer  Takayuki Fukui, MD, Shoichi Mori, MD, Kohei Yokoi, MD, Tetsuya.

Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer  Takayuki Fukui, MD, Shoichi Mori, MD, Kohei Yokoi, MD, Tetsuya.
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.
Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy 

Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy 
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.
Results of Surgical Treatment for Patients with Small Cell Lung Cancer

Results of Surgical Treatment for Patients with Small Cell Lung Cancer
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Hedgehog Signaling Pathway and Lung Cancer

Hedgehog Signaling Pathway and Lung Cancer
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation  Jean-Yves.

Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation  Jean-Yves.
Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non– Small-Cell Lung Cancer  Damien Urban, MBBS, B Med Sc, Jair Bar, MD, PhD,

Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non– Small-Cell Lung Cancer  Damien Urban, MBBS, B Med Sc, Jair Bar, MD, PhD,
Timing of Local and Distant Failure in Resected Lung Cancer: Implications for Reported Rates of Local Failure  Jessamy A. Boyd, MD, Jessica L. Hubbs,

Timing of Local and Distant Failure in Resected Lung Cancer: Implications for Reported Rates of Local Failure  Jessamy A. Boyd, MD, Jessica L. Hubbs,
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 

The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Samuel J. Wang, MD, PhD, C David Fuller, MD, Charles R. Thomas, MD 

Samuel J. Wang, MD, PhD, C David Fuller, MD, Charles R. Thomas, MD 
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Similar presentations

Ads by Google